Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 USD | +7.08% | +8.07% | -32.30% |
11/06 | Transcript : Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 | |
11/06 | Vistagen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Neutral |
Resistance | 3.940 | 4.370 | 6.740 |
Spread/Res. | -11.68% | -20.37% | -48.37% |
Spread/Supp. | +8.07% | +8.07% | +107.14% |
Support | 3.220 | 3.220 | 1.680 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- VTGN Stock
- Charts Vistagen Therapeutics, Inc.